Join Phil Lake, PhD and Kevin McCarthy as they share insights on the impact of incorporating the evaluation of full inflation recommended in the 2019 spirometry standards of the evaluation of spirometry acceptability.
Phil Lake, PhD
Sr Director, Respiratory Solutions, ERT
Phil Lake, PhD is a respiratory specialist at ERT who supports clients all around the world. Phil has held a variety of roles in drug development for nearly 20 years, predominantly focused on respiratory trials.
Prior to ERT, Phil held positions at SmithKline Beecham and GlaxoSmithKline. There, he worked on a number of anti-inflammatory agents, dual and triple combination therapy, monoclonal antibody studies, anti-infectives and some of the largest mechanistic studies looking at biomarkers within sputum and biopsy samples. He also has experience supporting a number of CROs as a respiratory specialist and as the head of project management. For the last 10 years, he has concentrated extensively on rare respiratory diseases, including Cystic Fibrosis and Idiopathic Pulmonary Fibrosis, covering a variety of drug mechanisms and medical devices. Phil was pivotal to some of the first centralised over read studies and is committed to driving improvements in lung function testing.
He completed his training at University College Cardiff and
Director, Respiratory Solutions at ERT
Kevin McCarthy has been working in the field of lung function testing since 1973. He was the Pulmonary Function Laboratories manager at the Cleveland Clinic Health System for nearly 40 years, retiring in 2016. Kevin’s research experience includes managing the pulmonary function quality control in two NIH-funded registries: patients with severe A1AT deficiency and LAM Registry, and was the site manager at Cleveland Clinic for the NETT study.
Kevin has published extensively on the topic of pulmonary function testing. He is a current member of the ATS PFT Committee and the ATS/ERS Task Force to update the standards for Lung Volume testing. He was a member of the ATS/ERS Task Force that updated the standards for Spirometry in 2019. Kevin is also a faculty member who presents the annual MGC Diagnostics Cardiorespiratory Diagnostics Seminar, providing excellent pulmonary function education for over 25 years.
Kevin has always been passionate about the quality of pulmonary function measurements. This passion has now moved to the clinical trial world, where data quality is critical. Measurements are to accurately answer the questions we are asking. He is now the Director of Respiratory Solutions at ERT for the US West Coast and Australia.